1. Home
  2. VTAK vs HAO Comparison

VTAK vs HAO Comparison

Compare VTAK & HAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTAK
  • HAO
  • Stock Information
  • Founded
  • VTAK 2002
  • HAO 2018
  • Country
  • VTAK United States
  • HAO China
  • Employees
  • VTAK N/A
  • HAO N/A
  • Industry
  • VTAK Medical/Dental Instruments
  • HAO
  • Sector
  • VTAK Health Care
  • HAO
  • Exchange
  • VTAK Nasdaq
  • HAO NYSE
  • Market Cap
  • VTAK 3.1M
  • HAO 3.3M
  • IPO Year
  • VTAK 2018
  • HAO 2024
  • Fundamental
  • Price
  • VTAK $0.30
  • HAO $1.18
  • Analyst Decision
  • VTAK
  • HAO
  • Analyst Count
  • VTAK 0
  • HAO 0
  • Target Price
  • VTAK N/A
  • HAO N/A
  • AVG Volume (30 Days)
  • VTAK 41.4M
  • HAO 132.2K
  • Earning Date
  • VTAK 08-13-2025
  • HAO 06-27-2025
  • Dividend Yield
  • VTAK N/A
  • HAO N/A
  • EPS Growth
  • VTAK N/A
  • HAO N/A
  • EPS
  • VTAK N/A
  • HAO 0.19
  • Revenue
  • VTAK $481,000.00
  • HAO $48,970,924.00
  • Revenue This Year
  • VTAK $822.86
  • HAO N/A
  • Revenue Next Year
  • VTAK $168.42
  • HAO N/A
  • P/E Ratio
  • VTAK N/A
  • HAO $5.93
  • Revenue Growth
  • VTAK 9.57
  • HAO 15.04
  • 52 Week Low
  • VTAK $0.16
  • HAO $0.84
  • 52 Week High
  • VTAK $8.40
  • HAO $173.25
  • Technical
  • Relative Strength Index (RSI)
  • VTAK 50.43
  • HAO 45.47
  • Support Level
  • VTAK $0.25
  • HAO $1.18
  • Resistance Level
  • VTAK $0.38
  • HAO $1.34
  • Average True Range (ATR)
  • VTAK 0.07
  • HAO 0.10
  • MACD
  • VTAK 0.01
  • HAO -0.01
  • Stochastic Oscillator
  • VTAK 18.46
  • HAO 25.00

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About HAO HAOXI HEALTH TECHNOLOGY LTD

Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. Haoxi has been rooted in the field of local online effect marketing for many years, serving customers in various industries at home and abroad, and its main business is the medical industry. It generates its revenue by providing one-stop online marketing solutions, in particular online short video marketing solutions, to advertisers through its media partners. The company provides customized marketing solutions by planning, producing, placing, and optimizing online ads, especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms.

Share on Social Networks: